BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Minocycline

A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

297+ PubMed studies analyzed · 6 RCTs · Evidence Score: 42.2

Research Domains

Minocycline has been studied across 16 research domains including ✨ Skin & Hair, 🦴 Bone & Joint, 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox. The primary research focus is ✨ Skin & Hair with 26% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Minocycline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Leuprolide
6 shared targets
Iproniazid
6 shared targets
Nateglinide
5 shared targets
Atrasentan
6 shared targets
Aztreonam
4 shared targets
Naproxen
6 shared targets
Pinacidil
4 shared targets
Midodrine
4 shared targets
Lamotrigine
5 shared targets
Nialamide
5 shared targets
Loading evidence profile...

This evidence profile for Minocycline is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.